Abstract Search

ea0026p244 | Pituitary | ECE2011

Hyperprolactinemia is a risk factor for radiological vertebral fractures in post-menopausal women

Mazziotti G , Mancini T , Mormando M , De Menis E , Bianchi A , Doga M , De Marinis L , Giustina A

Hyperprolactinemia may cause bone loss in pre-menopausal women and men. Data on fractures are scanty and it is still unclear which is the skeletal impact of hyperprolactinemia in post-menopausal women. The aim of this study was to evaluate the prevalence of vertebral fractures in post-menopausal women with hyperprolactinemia.Forty post-menopausal women (median age 57 years, range: 4781) with prolactin (PRL)-secreting adenoma and 119 control post-me...

0 shares

ea0029p820 | Endocrine tumours and neoplasia | ICEECE2012

Medical and Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Well and Moderately Differentiated Neuroendocrine Tumours

Bianchi A. , Iacovazzo D. , Lugli F. , Fusco A. , Chiloiro S. , Mormando M. , Tartaglione L. , Grande G. , Larghi A. , Schinzari G. , Doglietto G. , Margaritora S. , Perotti G. , Rindi G. , Pontecorvi A. , De Marinis L.

Introduction: Peptide receptor radionuclide therapy (PRRT) is a treatment choice for inoperable or metastasized neuroendocrine tumours and this therapy seems more effective in the biochemical and volume control of disease than somatostatin analogues (SSA).Aims: To demonstrate the efficacy of medical therapy with SSA and PRRT in patients with well and moderately differentiated neuroendocrine tumours.Materials and methods: We evaluat...

0 shares

Endocrine Abstracts

Hyperprolactinemia is a risk factor for radiological vertebral fractures in post-menopausal women

Medical and Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Well and Moderately Differentiated Neuroendocrine Tumours

BiosciAbstracts